These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6331295)

  • 1. Antibacterial activity of coumermycin alone and in combination with other antibiotics.
    Neu HC; Chin NX; Labthavikul P
    Antimicrob Agents Chemother; 1984 Jun; 25(6):687-9. PubMed ID: 6331295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activity of CI934, a new fluoroquinolone, alone and in combination with coumermycin, against gram-positive bacteria.
    van der Auwera P; Vandermies A; Grenier P; Klastersky J
    Drugs Exp Clin Res; 1987; 13(3):125-32. PubMed ID: 3622241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
    Hirschl AM; Georgopoulos A; Stanek G; Breyer S; Rotter ML
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):541-8. PubMed ID: 3164157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus.
    Meyers BR; Srulevitch ES; Hirschman SZ
    Antimicrob Agents Chemother; 1985 Nov; 28(5):706-7. PubMed ID: 3853964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of teicoplanin and vancomycin disk susceptibility tests.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1986 Jan; 23(1):100-3. PubMed ID: 2939101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
    Van der Auwera P; Klastersky J
    Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of coumermycin against methicillin-resistant staphylococci: a comparison with six other agents.
    Thomas MG; Lang SD
    J Antimicrob Chemother; 1986 Aug; 18(2):171-5. PubMed ID: 3639086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
    Aldridge KE; Janney A; Sanders CV
    Antimicrob Agents Chemother; 1985 Nov; 28(5):634-8. PubMed ID: 2936300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
    Floyd-Reising SA; Kelley SG; Hindler JA; Young LS
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):301-6. PubMed ID: 3472704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC; Chin NX; Neu NM
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
    Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1983 Nov; 24(5):754-63. PubMed ID: 6229216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin.
    Gombert ME; Aulicino TM
    Antimicrob Agents Chemother; 1984 Dec; 26(6):933-4. PubMed ID: 6570085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
    Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
    Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of teichomycin compared with those of other antibiotics.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1983 Sep; 24(3):425-8. PubMed ID: 6227282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of coumermycin against clinical isolates of staphylococci.
    Guillemin MN; Miles HM; McDonald MI
    Antimicrob Agents Chemother; 1986 Apr; 29(4):608-10. PubMed ID: 3707109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
    Zurenko GE; Yagi BH; Schaadt RD; Allison JW; Kilburn JO; Glickman SE; Hutchinson DK; Barbachyn MR; Brickner SJ
    Antimicrob Agents Chemother; 1996 Apr; 40(4):839-45. PubMed ID: 8849237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
    Van der Auwera P; Joly P
    J Antimicrob Chemother; 1987 Mar; 19(3):313-20. PubMed ID: 3032884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
    Perronne CM; Malinverni R; Glauser MP
    Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.